Hepatitis C and Cryoglobulinemic Vasculitis
A study of 1,294 patients reveals that hepatitis C-related cryoglobulinemic vasculitis now has better survival outcomes than autoimmune-related cases due to advancements in antiviral treatments. The research highlights that non-viral and autoimmune causes are becoming the primary drivers of severe clinical events in this patient population.
Why it matters
The findings demonstrate how medical breakthroughs in treating viral infections can shift the clinical landscape and prognosis for complex systemic diseases.
HEPATITIS C cases of cryoglobulinemic vasculitis show improved event-free survival compared with those having autoimmune diseases . Historically recognized as the primary indicator of adverse outcomes in mixed cryoglobulinemia, chronic hepatitis C virus infectio n is now linked to superior event-free survival following the therapeutic revolution of direct-acting antiviral agents . Findings from the EuroCryo multicenter cohort study, which investigated 1,294 patients across 18 European referral centers, establish that non-viral and autoimmune etiologies now dominate the clinical landscape . Underlying autoimmune diseases accounted for 23 percent of all presentations, led predominantly by Sjögren disease, whereas essential forms comprised 27 percent and hepatitis C represented 36 percent .
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in